Related Experiment Video
Updated: Aug 6, 2025
Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Efficacy and prognosis of neuroendoscopy-assisted surgery for chronic subdural hematoma
Baolin Ma1, Huping Song2, Wuyong Lin3
1Baolin Ma, Department of Neurosurgery, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, 361022, China.
Insights
Neuroendoscopy-assisted surgery for chronic subdural hematoma (CSDH) offers superior outcomes compared to burr-hole drainage. This minimally invasive approach reduces recurrence rates and improves patient prognosis, making it a valuable treatment option.
Area of Science:
- Neurosurgery
- Minimally Invasive Surgery
Background:
- Chronic subdural hematoma (CSDH) is a common neurosurgical condition requiring effective treatment.
- Traditional burr-hole drainage is a standard surgical approach for CSDH.
Purpose of the Study:
- To evaluate the clinical efficacy and prognosis of neuroendoscopy-assisted surgery for CSDH.
- To compare neuroendoscopy-assisted surgery with traditional burr-hole drainage.
Main Methods:
- Retrospective analysis of 80 CSDH patients treated between March 2018 and June 2020.
- Comparison of a control group (burr-hole drainage, n=32) and an observation group (neuroendoscopy-assisted surgery, n=48).
- Assessment of hematoma clearance, surgical indicators, complications, recurrence rates, and functional outcomes.
Main Results:
- Higher hematoma clearance rate (92.59%) in the neuroendoscopy group versus burr-hole group (77.78%).
- Lower postoperative complication rate and recurrence rate (1.85%) in the neuroendoscopy group.
- Improved limb motor function, daily living ability, and lower Markwalder grading scores in the neuroendoscopy group post-surgery.
Conclusions:
- Neuroendoscopy-assisted surgery is a safe and effective treatment for CSDH.
- This technique demonstrates superiority over traditional burr-hole drainage by reducing recurrence and improving patient prognosis.
- Neuroendoscopy-assisted surgery is recommended for clinical application in CSDH management.
Objective:
This paper aims to analyze the clinical effect and prognosis of neuroendoscopy-assisted surgery for chronic subdural hematoma (CSDH).
Methods:
The clinical data of CSDH patients who underwent surgery between March 2018 and June 2020 in the Department of Neurosurgery of the First Affiliated Hospital of Xiamen University were retrospectively collected and analyzed. Eighty patients with CSDH who met the inclusive criteria were selected. A control group (32 cases treated with burr hole drainage) and an observation group (48 cases treated with neuroendoscopy-assisted surgery) were set according to different operation methods. The hematoma clearance rate, surgery-related indicators, related complications, hematoma recurrence rate and related prognostic indicators of the two groups were compared and analyzed.
Result:
The postoperative hematoma clearance rate of the observation group was 92.59%, which was higher than that of the control group (77.78%) (P<0.05). The operation time of the observation group was longer than that of the control group (P<0.05). The postoperative hospitalization time of the observation group was shorter than that of the control group (P<0.05). The postoperative complication rate of the observation group was lower than that of the control group (P<0.05). The recurrence rate of hematoma in the observation group in the six-month postoperative follow-up was 1.85%, which was lower than that in the control group (P<0.05). The limb motor function and daily living ability score of the observation group were higher than those of the control group, and the Markwalder grading score was lower than that of the control group (P<0.05).
Conclusion:
Neuroendoscopy-assisted treatment which is safe and effective is superior to traditional burr-hole drainage surgery. It can reduce the recurrence rate; thus, it is worth advocating and applying.
